Department of General Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Department of Gastric Surgery, Fudan University Shanghai Cancer Center, Shanghai, 200032, China.
Surg Endosc. 2024 Nov;38(11):6726-6735. doi: 10.1007/s00464-024-11293-w. Epub 2024 Sep 26.
To analyze the diagnostic efficiency of the four absolute endoscopic submucosal dissection (ESD) indications for lymph node metastasis (LNM) of Chinese patients with early gastric cancer (EGC).
We retrospectively analyzed EGC patients who underwent radical D2 gastrectomy from January 2019 to December 2022. We evaluated the rate of LNM, false-negative rate, and negative predictive value of the four ESD indications.
Of enrolled 2722 EGC patients, 388 (14.3%) patients presented LNM. Tumor size > 2 cm, ulceration, submucosal invasion, undifferentiated type, and lymphovascular invasion were independent risk factors of LNM in patients with EGC. 1062 (39%) cases of EGC conformed to the four EDS indications; however, 4% of them had LNM. 451 cases were fully in accord with the fourth ESD indication (undifferentiated intramucosal carcinoma without ulceration and a maximum lesion diameter of ≤ 2 cm), and 35 of them had LNM, with a false-negative rate (FNR) of 9.02% and a negative predictive value (NPV) of 92.24%. There was significant difference among the four indications in terms of the rate of LNM (1.0% vs 1.5% vs 1.3% vs 7.8%, P < 0.001), FNR (1.03% vs 0.52% vs 0.26% vs 9.02%, P < 0.001), and NPV (98.99% vs 98.53% vs 98.75% vs 92.24%, P < 0.001).
Overall, the fourth ESD indication was associated with a high rate of LNM compared to the other three indications. Thus, it might not be safe to classify it as an absolute indication in Chinese patients with EGC.
分析四项绝对内镜黏膜下剥离术(ESD)适应证对中国早期胃癌(EGC)患者淋巴结转移(LNM)的诊断效率。
我们回顾性分析了 2019 年 1 月至 2022 年 12 月期间接受根治性 D2 胃切除术的 EGC 患者。评估了四项 ESD 适应证的 LNM 发生率、假阴性率和阴性预测值。
共纳入 2722 例 EGC 患者,其中 388 例(14.3%)患者存在 LNM。肿瘤大小>2cm、溃疡、黏膜下浸润、未分化型和淋巴管浸润是 EGC 患者 LNM 的独立危险因素。1062 例(39%)EGC 病例符合四项 EDS 适应证,但其中 4%存在 LNM。451 例完全符合第四项 ESD 适应证(无溃疡的未分化黏膜内癌,最大病变直径≤2cm),其中 35 例存在 LNM,假阴性率(FNR)为 9.02%,阴性预测值(NPV)为 92.24%。四项适应证的 LNM 发生率(1.0%比 1.5%比 1.3%比 7.8%,P<0.001)、FNR(1.03%比 0.52%比 0.26%比 9.02%,P<0.001)和 NPV(98.99%比 98.53%比 98.75%比 92.24%,P<0.001)差异有统计学意义。
总体而言,第四项 ESD 适应证与其他三项适应证相比,LNM 发生率较高。因此,在中国 EGC 患者中,将其归类为绝对适应证可能并不安全。